Nath Bio-Genes (India) Limited
Share Price Target & Analysis
NSE:NATHBIOGEN
VWAP
Open
Close
High
Low
52 Week High
-0.02 (-0.01%)
NATHBIOGEN
(PHARMA)Turnaround Potential
52 Week Low
EPS
PE
PB
Superior
Quality
Iron
Valuation
#Analysis
NSE: NATHBIOGEN Share Price Financial Analysis & Valuation
Nath Bio-Genes (India) Limited (NATHBIOGEN) is broadly categorized in PHARMA segment industry which deals in Pharmaceuticals vertical.
It is one of Micro Cap company with Market Capitalization of Rs 496 (in Cr). Total number of free float shares are 1.9 (in Lacs).
Nath Bio-Genes (India) Limited is listed on NSE with Exchange ID - INE448G01010 and trading code is NSE:NATHBIOGEN with short name Nath Bio-Genes.
In the past 1 year, Nath Bio-Genes (India) Limited has declared an equity dividend of Rs 2 per share. At the current share price of NATHBIOGEN at Rs 154.97, this results in a dividend yield of 1.29 %.
As per the Fundamental Analysis of NSE:NATHBIOGEN, which uses revenues, earnings, future growth, financial ratios, return on equity, profit margins, and other data to determine NATHBIOGEN underlying value and future prospects. All of this data is available in NATHBIOGEN financial statements.
Quality of the Stock: As per the fundamental analysis of NSE:NATHBIOGEN, it is clearly understood that NATHBIOGEN is Superior performer in terms of earnings and profit margins with an EPS of 28.6. NSE:NATHBIOGEN book value per share as of today is 361.65. The current price to book ratio for NATHBIOGEN as of Mar 06, 2026 is 0.43.
Valuation of the Stock: The current valuation of NATHBIOGEN stock is like Iron which means currently the stock is Inexpensive. Now, it's totally depends upon the risk appetite of an investor and risk-reward ratio of NATHBIOGEN whether to BUY this stock at current valuation. The delivery percentage of NATHBIOGEN is 87.18% is very crucial parameter which shows that 87.18% investors are anticipating that the price of NATHBIOGEN share should go up with VWAP at 154.72.
Now, the main question is whether to BUY or SELL, NSE:NATHBIOGEN at current valuation.
As per latest Analysis No. #930:-
⇑ STRONG BUY NATHBIOGEN if All Greens
⇗ BUY NATHBIOGEN (at Lower Levels) if any 2 Greens
⇒ NEUTRAL or HOLD NATHBIOGEN (With Stop Loss) if only 1 Green
⇘ SELL NATHBIOGEN if NO Green Indicator
NSE: NATHBIOGEN Share Price Today (Mar 06, 2026)
(Nath Bio-Genes (India) Limited Daily Analysis on the basis of NATHBIOGEN Intraday Graph & Trend)
Nath Bio-Genes (India) Limited share price moved Down by -0.01% from its previous close of Rs 154.99. NATHBIOGEN stock last traded price is 154.97. NATHBIOGEN share price trend is Down with a total of 3581 stocks traded till now. It has touched an intraday high of Rs 157.89 and an intraday low of Rs 153.5. The NATHBIOGEN trading at 154.97, Down by Rs. -0.02, or -0.01 percent which suggests that most of the Traders are anticipating that the price of NATHBIOGEN share should go Down.
NSE: NATHBIOGEN Share Price Tomorrow Prediction
(Nath Bio-Genes (India) Limited Share Price Prediction for Tomorrow & future forecast is based on Current Trend of NATHBIOGEN)
Nath Bio-Genes (India) Limited share price moved Down by -0.01%. NATHBIOGEN share price short term trend is Down. It suggests that NATHBIOGEN Share Price for Tomorrow remains the same with VWAP at 154.72 will be treated as stop loss for intraday traders. Nath Bio-Genes (India) Limited Long term investors can follow the NATHBIOGEN long term trend as mentiond in future forecast table.
NSE Code |
NSE: NATHBIOGEN |
NATHBIOGEN Share Price Today |
154.97 |
NATHBIOGEN Share Price Target Prediction for 2026 ^ |
142.6 - 207 |
NATHBIOGEN Share Price Target Prediction for 2027*^ |
207 - 273.6 |
NATHBIOGEN Share Price Target Prediction for 2028*^ |
273.6 - 294.7 |
NATHBIOGEN Share Price Target Prediction for 2029*^ |
309 |
NATHBIOGEN Share Price Target Prediction for 2030*^ |
320 |
NATHBIOGEN Share Price Target Prediction for 2035*^ |
351 |
| NATHBIOGEN Current Book Value 2025 |
359.8 |
*Nath Bio-Genes (India) Limited Short Term & Long Term share price target is based on current financial year earings of the company.
^NATHBIOGEN share price target prediction for 2025 2026 2027 to 2030 is based on current market scenario, future forecast & growth assumptions, they might change subject to market sentiments.
NATHBIOGEN Technical Analysis
Candlestick Pattern: @229.67| MA | Simple | Action S1 | Expo | Action E2 |
|---|---|---|---|---|
| MA_5 | 228.72 | BUY | 226.75 | BUY |
| MA_12 | 216.66 | BUY | 218.63 | BUY |
| MA_20 | 211.62 | BUY | 213.54 | BUY |
| MA_32 | 204.01 | BUY | 205.45 | BUY |
| MA_50 | 195.33 | BUY | 198.46 | BUY |
| MA_100 | 177.67 | BUY | 189.4 | BUY |
| MA_200 | 182.32 | BUY | 187.26 | BUY |
| Trend Oscillators | Value | Action |
|---|---|---|
| Bollinger Bands | 211.62 | Uptrend |
| MACD | 1.62 | BUY |
| ADX | 38.77 | Strong Trend |
| DMI (+/-) | 28.03 / 15.85 | Uptrend |
| Momentum Oscillators | Value | Action |
|---|---|---|
| RSI | 68.15 | Neutral |
| STOCHASTIC_K (Fast) | 59.91 | Neutral |
| STOCHASTIC_D (Slow) | 72.51 | Neutral |
| CCI | 86 | Neutral |
| PSAR | 213.91 | BUY |
| TRUE RANGE | 12 | BUY |
| ATR | 8.96 | BUY |
| WILLIAMS R | -23.31 | Neutral |
| TRIX | 0 | Neutral |
| STOCHASTIC RSI K | 17.14 | Oversold |
| STOCHASTIC RSI D | 39.05 | Neutral |
| MOMENTUM | 23.87 | BUY |
| Duration | Value |
|---|---|
| 1 Year | -9.5% |
| 3 Months | 54.7% |
| 1 Month | 11.6% |
| 1 Week | 6.43% |
| Action | Overall (%) |
|---|---|
| BUY | 73% |
| NEUTRAL / HOLD | 23% |
| SELL | 3% |
Most popular Questions & Answers about NATHBIOGEN
Nath Bio-Genes (India) Limited stock last traded price is 154.97. NATHBIOGEN share price moved Down by -0.01% from its previous close of Rs 154.99.
Nath Bio-Genes (India) Limited share price trend is Down with a total of 3581 stocks traded till now. It has touched an intraday high of Rs 256.38845 and an intraday low of Rs 153.5. The NATHBIOGEN trading at 154.97, Down by Rs. -0.02, or -0.01 percent which suggests that most of the Traders are anticipating that the price of NATHBIOGEN share should go Down and the Stop Loss will be around 154.72.
The market cap of Nath Bio-Genes (India) Limited is ₹496 (in Cr) as of Mar 05, 2026.
The current price to earning ratio for Nath Bio-Genes (India) Limited as of Mar 05, 2026 is 9.25.
The current price to book ratio for Nath Bio-Genes (India) Limited as of Mar 05, 2026 is 0.43.
The highest price of Nath Bio-Genes (India) Limited stock is ₹238.69 in the last 52-week.
The lowest price of Nath Bio-Genes (India) Limited stock is ₹136 in the last 52-week.
Nath Bio-Genes (India) Limited share trading at ₹154.97, Down by Rs. -0.02, or -0.01 percent which suggests that most of the traders are anticipating that the price of NATHBIOGEN share should go Down.
In 2025, Stock price target for Nath Bio-Genes (India) Limited (NATHBIOGEN) are ₹142.6 on downside and ₹207 on upside. Nath Bio-Genes (India) Limited share price target is based on current financial year earings of the company.
In 2026, Stock price target for Nath Bio-Genes (India) Limited (NATHBIOGEN) are ₹207 on downside and ₹273.6 on upside. Nath Bio-Genes (India) Limited share price target is based on forecasted future earnings of the company.
In 2027, Stock price target for Nath Bio-Genes (India) Limited (NATHBIOGEN) are ₹273.6 on downside and ₹294.7 on upside. Nath Bio-Genes (India) Limited share price target is based on Discounted Cash Flow (DCF) method uses the projected future cash flows of the business.
In next five years, Stock price target for Nath Bio-Genes (India) Limited (NATHBIOGEN) will be around ₹320 Nath Bio-Genes (India) Limited share price target is based on market scenario & growth assumptions, they might change subject to market sentiments and forecasted future earnings of NATHBIOGEN.
The price of Nath Bio-Genes (India) Limited (NATHBIOGEN) shares moved by -0.01%. The short-term trend for NATHBIOGEN share price is Down. It implies that the share price of NATHBIOGEN will stay the same tomorrow and that intraday traders should treat VWAP at 154.72 as a stop loss. Investors with a long-term outlook can track NATHBIOGEN long-term trajectory, which is indicated in the future forecast table.
Estimated DCF Value of NATHBIOGEN stock is 342.9. Compared to the current market price of 154.97 INR, the NATHBIOGEN stock is Undervalued by 54.8%.
As per the fundamental analysis of Nath Bio-Genes (India) Limited (NATHBIOGEN), it is of Superior quality in terms of earnings and profit margins with an EPS of 28.6. Nath Bio-Genes (India) Limited book value per share as of today is 361.65. The current price to book ratio for NATHBIOGEN as of Mar 06, 2026 is 0.43.
NSE:NATHBIOGEN News & Other Useful Information about NATHBIOGEN Share Price
Peer Comparison of NSE: NATHBIOGEN
The Peers list includes companies operating in the same industry and having comparable market cap.
Sector: Pharmaceuticals
| Company | Price | EPS | BV |
|---|---|---|---|
| SUNPHARMA | 1714.80 | 16.77 | 99.25 |
| DIVISLAB | 6196.50 | 94.7 | 578.26 |
| MEDICAMEQ | 363.95 | 6.47 | 200.56 |
| CIPLA | 1353.20 | 57.14 | 411.56 |
| DRREDDY | 1281.00 | 55.59 | 377.56 |
| PGHH | 5215.00 | 189.8 | 373.34 |
| TORNTPHARM | 4032.00 | 62.26 | 249.83 |
| BIOCON | 374.75 | 4.12 | 99.48 |
| LUPIN | 2225.70 | 126.08 | 595.77 |
| ALKEM | 5775.00 | 204.32 | 1142.87 |